William V. Tamborlane

46.9k total citations · 8 hit papers
377 papers, 30.0k citations indexed

About

William V. Tamborlane is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, William V. Tamborlane has authored 377 papers receiving a total of 30.0k indexed citations (citations by other indexed papers that have themselves been cited), including 317 papers in Endocrinology, Diabetes and Metabolism, 204 papers in Surgery and 146 papers in Genetics. Recurrent topics in William V. Tamborlane's work include Diabetes Management and Research (267 papers), Pancreatic function and diabetes (197 papers) and Diabetes and associated disorders (141 papers). William V. Tamborlane is often cited by papers focused on Diabetes Management and Research (267 papers), Pancreatic function and diabetes (197 papers) and Diabetes and associated disorders (141 papers). William V. Tamborlane collaborates with scholars based in United States, United Kingdom and Israel. William V. Tamborlane's co-authors include Robert S. Sherwin, Sonia Caprio, Roy W. Beck, Sara E. Taksali, Mary Savoye, James Dziura, Stephanie A. Amiel, Ram Weiss, Stuart A. Weinzimer and Tania S. Burgert and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

William V. Tamborlane

375 papers receiving 28.6k citations

Hit Papers

Obesity and the Metabolic Syndrome in Children ... 1986 2026 1999 2012 2004 2019 2002 2015 1986 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Obesity and the Metabolic Syndrome in Children and Adolescents
    2004 2.6k citations William V. Tamborlane, Robert S. Sherwin et al. New England Journal of Medicine profile →
  2. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
    2019 1.4k citations Nicole C. Foster, Roy W. Beck et al. Diabetes Technology & Therapeutics profile →
  3. Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity
    2002 1.3k citations William V. Tamborlane, Robert S. Sherwin et al. New England Journal of Medicine profile →
  4. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
    2015 983 citations Kellee M. Miller, Nicole C. Foster et al. Diabetes Care profile →
  5. Impaired Insulin Action in Puberty
    1986 767 citations Robert S. Sherwin, William V. Tamborlane et al. New England Journal of Medicine profile →
  6. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
    2010 651 citations Richard M. Bergenstal, William V. Tamborlane et al. New England Journal of Medicine profile →
  7. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
    2017 415 citations Stuart A. Weinzimer, William V. Tamborlane et al. Diabetes Technology & Therapeutics profile →
  8. The T1D Exchange Clinic Registry
    2012 346 citations Roy W. Beck, William V. Tamborlane et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William V. Tamborlane United States 88 21.6k 11.4k 10.1k 4.3k 3.7k 377 30.0k
David B. Dunger United Kingdom 95 14.2k 0.7× 7.4k 0.6× 9.0k 0.9× 4.3k 1.0× 4.0k 1.1× 597 32.2k
Reinhard W. Holl Germany 72 12.1k 0.6× 6.3k 0.6× 8.0k 0.8× 1.7k 0.4× 1.4k 0.4× 648 18.6k
Robert S. Sherwin United States 74 10.2k 0.5× 5.2k 0.5× 3.5k 0.3× 2.9k 0.7× 5.3k 1.4× 208 21.2k
Silva Arslanian United States 70 9.2k 0.4× 3.3k 0.3× 3.2k 0.3× 7.7k 1.8× 4.8k 1.3× 242 21.0k
Lawrence M. Dolan United States 66 8.3k 0.4× 4.0k 0.3× 4.4k 0.4× 2.8k 0.7× 1.9k 0.5× 257 15.6k
Sonia Caprio United States 70 9.6k 0.4× 4.0k 0.4× 2.4k 0.2× 7.9k 1.9× 7.0k 1.9× 260 24.3k
Roy W. Beck United States 92 14.4k 0.7× 9.6k 0.8× 8.6k 0.8× 1.0k 0.2× 934 0.2× 391 33.4k
Francine Kaufman United States 52 7.0k 0.3× 3.7k 0.3× 3.8k 0.4× 2.8k 0.7× 1.5k 0.4× 190 12.6k
Lori M. Laffel United States 67 12.3k 0.6× 5.0k 0.4× 5.3k 0.5× 752 0.2× 1.3k 0.4× 309 17.4k
Simon Heller United Kingdom 67 16.1k 0.7× 5.6k 0.5× 4.5k 0.4× 625 0.1× 1.4k 0.4× 396 20.3k

Countries citing papers authored by William V. Tamborlane

Since Specialization
Citations

This map shows the geographic impact of William V. Tamborlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William V. Tamborlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William V. Tamborlane more than expected).

Fields of papers citing papers by William V. Tamborlane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William V. Tamborlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William V. Tamborlane. The network helps show where William V. Tamborlane may publish in the future.

Co-authorship network of co-authors of William V. Tamborlane

This figure shows the co-authorship network connecting the top 25 collaborators of William V. Tamborlane. A scholar is included among the top collaborators of William V. Tamborlane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William V. Tamborlane. William V. Tamborlane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gubitosi‐Klug, Rose, Barbara H. Braffett, Ionut Bebu, et al.. (2022). Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study. Diabetes Care. 45(3). 659–665. 17 indexed citations
2.
Tamborlane, William V., Lori M. Laffel, Naim Shehadeh, et al.. (2022). Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. The Lancet Diabetes & Endocrinology. 10(5). 341–350. 47 indexed citations
3.
Malone, John I., Xiaoyu Gao, Gayle M. Lorenzi, et al.. (2022). Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced Retinopathy. Diabetes Care. 46(4). 680–686. 2 indexed citations
4.
Wolf, Risa M., Peiyao Cheng, Robin L. Gal, et al.. (2022). Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study. Pediatric Diabetes. 23(4). 439–446. 3 indexed citations
5.
Commissariat, Persis, Marisa E. Hilliard, Kellee M. Miller, et al.. (2020). Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 Years Old with Type 1 Diabetes. Diabetes Technology & Therapeutics. 22(9). 697–700. 7 indexed citations
6.
DiMeglio, Linda A., Lauren Kanapka, Daniel J. DeSalvo, et al.. (2020). Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study. Diabetic Medicine. 37(8). 1308–1315. 16 indexed citations
7.
Tamborlane, William V., Margarita Barrientos‐Pérez, Udi Fainberg, et al.. (2019). Liraglutide in Children and Adolescents with Type 2 Diabetes. New England Journal of Medicine. 381(7). 637–646. 222 indexed citations
8.
Wagner, Julie, Nancy M. Petry, Kate Weyman, et al.. (2019). Glucose management for rewards: A randomized trial to improve glucose monitoring and associated self‐management behaviors in adolescents with type 1 diabetes. Pediatric Diabetes. 20(7). 997–1006. 15 indexed citations
9.
Hilliard, Marisa E., Wendy Levy, Barbara J. Anderson, et al.. (2019). Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(9). 493–498. 94 indexed citations
10.
Name, Michelle Van, Georgeanna J. Klingensmith, Bryce Nelson, et al.. (2019). Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model. Diabetes Technology & Therapeutics. 22(4). 330–336. 5 indexed citations
11.
McGill, Janet B., Mengdi Wu, Rodica Pop‐Busui, et al.. (2019). Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network. Journal of Diabetes and its Complications. 33(10). 107400–107400. 2 indexed citations
12.
Klingensmith, Georgeanna J., Stefanie Lanzinger, William V. Tamborlane, et al.. (2018). Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries. Pediatric Diabetes. 19(7). 1156–1163. 15 indexed citations
13.
Tamborlane, William V., Pei-Yao Chang, Craig Kollman, et al.. (2018). Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatric Diabetes. 19(8). 1379–1384. 11 indexed citations
14.
Gubitosi‐Klug, Rose, Barbara H. Braffett, Neil H. White, et al.. (2017). Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care. 40(8). 1010–1016. 102 indexed citations
15.
Libman, Ingrid, Kellee M. Miller, Linda A. DiMeglio, et al.. (2015). Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. Publisher. 10 indexed citations
16.
Cengiz, Eda, Stuart A. Weinzimer, Jennifer L. Sherr, et al.. (2013). Faster In and Faster Out: Accelerating Insulin Absorption and Action by Insulin Infusion Site Warming. Diabetes Technology & Therapeutics. 16(1). 20–25. 25 indexed citations
17.
Urban, Andrea, et al.. (2013). Delayed hypoglycemia following exercise in an athletic teenager with type 1 diabetes. 6(1). 11–13. 1 indexed citations
18.
Xing, Dongyuan, Craig Kollman, Roy W. Beck, et al.. (2011). Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. 13(3). 351–358. 103 indexed citations
19.
Buckingham, Bruce A., Roy W. Beck, William V. Tamborlane, et al.. (2007). Continuous Glucose Monitoring in Children with Type 1 Diabetes. The Journal of Pediatrics. 151(4). 388–393.e2. 107 indexed citations
20.
Anderson, Adam W., Rubina A. Heptulla, Naomi Driesen, et al.. (2006). Effects of hypoglycemia on human brain activation measured with fMRI. Magnetic Resonance Imaging. 24(6). 693–697. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David B. Dunger Breakdown of academic impact, for papers by Reinhard W. Holl Breakdown of academic impact, for papers by Robert S. Sherwin Breakdown of academic impact, for papers by Silva Arslanian Breakdown of academic impact, for papers by Lawrence M. Dolan Breakdown of academic impact, for papers by Sonia Caprio Breakdown of academic impact, for papers by Roy W. Beck Breakdown of academic impact, for papers by Francine Kaufman Breakdown of academic impact, for papers by Lori M. Laffel Breakdown of academic impact, for papers by Simon Heller
Rankless by CCL
2026